This company listing is no longer active
0H9M Stock Overview
A technology company, engages in developing software for the health and care sector. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Carasent AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 20.60 |
| 52 Week High | NOK 20.60 |
| 52 Week Low | NOK 10.00 |
| Beta | 0.50 |
| 1 Month Change | 3.78% |
| 3 Month Change | n/a |
| 1 Year Change | 97.32% |
| 3 Year Change | -40.63% |
| 5 Year Change | n/a |
| Change since IPO | 171.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0H9M | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.1% | -0.7% |
| 1Y | 97.3% | 8.1% | 5.3% |
Return vs Industry: 0H9M exceeded the UK Healthcare Services industry which returned 33.3% over the past year.
Return vs Market: 0H9M exceeded the UK Market which returned 8.6% over the past year.
Price Volatility
| 0H9M volatility | |
|---|---|
| 0H9M Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.8% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0H9M's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0H9M's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 169 | Daniel Ohman | carasent.com |
Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services.
Carasent AB (publ) Fundamentals Summary
| 0H9M fundamental statistics | |
|---|---|
| Market cap | NOK 1.53b |
| Earnings (TTM) | -NOK 7.94m |
| Revenue (TTM) | NOK 264.80m |
5.8x
P/S Ratio-192.2x
P/E RatioIs 0H9M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0H9M income statement (TTM) | |
|---|---|
| Revenue | NOK 264.80m |
| Cost of Revenue | NOK 42.52m |
| Gross Profit | NOK 222.27m |
| Other Expenses | NOK 230.21m |
| Earnings | -NOK 7.94m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 83.94% |
| Net Profit Margin | -3.00% |
| Debt/Equity Ratio | 0% |
How did 0H9M perform over the long term?
See historical performance and comparisonDividends
8.7%
Current Dividend Yield-230%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/05 03:03 |
| End of Day Share Price | 2024/11/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Carasent AB (publ) is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Commissioned Research |
| Ole-Andreas Krohn | DNB Markets |
| Christoffer Bjørnsen | DNB Markets |